You are reading this message because you cannot see our css files. To view this page properly please upgrade to the latest version of your browser. Thank you.

 
SCIENCE|BUSINESS LIFE SCIENCES BRIDGE
A bridge to span the gaps between industry, academia and policy
WHAT'S NEW
investment

Reading the runes for venture capital

Ireland’s largest-ever healthcare venture capital fund makes an optimistic debut as one of the UK’s longest-standing VC supporters of high tech start-ups calls it quits.

biotech, DNA

Biotech’s risk profile is shifting

Biotechnology and risk have always been synonymous. But now those risks are evolving and growing, exposing companies to fresh hazards.

research

Growth in industry partnerships for
diseases of the developing world

Numbers of public–private partnerships addressing unmet medical needs in the developing world are growing fast.

nanomedicine

Nanomedicine: Going small for big results

By carefully manipulating materials at the nanoscale, researchers hope to devise more effective and personalised medical diagnostics and therapies.

LIFE SCIENCES EVENTS
6 November 2008, London Future trends in healthcare access and delivery
Meeting the needs of all stakeholders in future healthcare – a real possibility?
LIFE SCIENCES NEWS & VIEWS
15 MayOverseas partner labs must comply with new UK rules on animal research S
15 MayDrive to simplify legislation on medical devices
15 MayReading the runes for venture capital
15 MayNordiag in-licenses antigen technology from Russia for infectious disease testing
15 MayStem cell consortium launches in Paris with €3M for research
15 MayYork University spin-out acquired
15 MayFreiburg University and Genedata extend systems biology collaboration
14 MayMediGene shares soar on bid speculation S
14 MayNew fruit fly model of human ageing S
14 MayCyDen raises £2.8M in third-round funding
14 MayVetCell: Treating horses with collapsed heels S
08 MayProQinase and CRELUX collaborate on protein kinase inhibition
08 MayBiotech’s risk profile is shifting S
08 MayEuropean innovators honoured S
07 MayAstraZeneca spin-out raises total €25M
07 MayHorizon Discovery and Hypoxium to develop personalised anti-cancer agents
07 MayIsogenica acquires Karyon; raises £2 million
07 MayUK business angels lead investment in US Nobel prize technology
07 MayIreland’s blossoming biologics sector secures big investment by Pfizer
07 MayPharma-sponsored studentships down in the UK S
07 MaySt Andrews: Molecules that protect anti-tumour gene p53 S
07 MayInion: Bone regrowth technology S
30 AprilETH Zürich: In vitro prion diagnostic tool S
30 AprilDresden: Proof of principle for new approach to treating Alzheimer’s S
30 AprilImperial Innovations declares six-month results
30 AprilBaltic meeting to discuss bio-based SME financing
30 AprilGrowth in drug industry partnerships for diseases of the developing world S
30 AprilCrucell in licence deal with Toyobo Gene Analysis
29 AprilHebrew University: Medical images via mobile S
29 AprilITI wants to fund programme in eye diseases S

subscribers only button Subscribers only

fact check
Quote

“We don’t support the drafting of new legislation but prefer to use other ways to cooperate.”

Anonymous British diplomat on plans to create the European Research Area